CYCN READ THE FULL CYCN RESEARCH REPORT Initiating Coverage We are initiating coverage of Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) with a valuation of $8.00. Cyclerion is a clinical-stage ...
A start-up claims dream communication is possible, but scientists say sleeping brains interaction remains unproven and speculative.
Timely access to pediatric neurology care after a first seizure is critical, yet many children face wait times of weeks or months before seeing a specialist. These delays can contribute to missed or ...
Growth is fueled by breakthroughs in non-invasive EEG and fNIRS systems, hybrid BCIs, and graphene-enabled electrodes that ...
Koch, who studied vision, thought that by measuring people's brain responses as they looked at special optical illusions, ...
Artificial intelligence may make doctors worse, but it exposes an old problem we've ignore ...
A new, gut-turning slang term for a symptom of prolonged cannabis use has started to circulate, and it's dividing experts. Medical professionals say the symptom should serve as a warning, while ...
Explore how machine learning, EEG data, and high-performance computing can help detect signs of consciousness. Donald Trump gives update on "Arc de Trump" Ford workers told their CEO ‘none of the ...
The new face of the military will be one without facial hair, even if that means enduring painful razor bumps. Service members who require a medical shaving waiver for more than one year must be ...
Wegovy (semaglutide) is considered a safe and effective treatment for the conditions it’s approved to treat. Possible problems with long-term use include pancreatitis, gallbladder disease, and kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results